Comments to CMS Regarding End-Stage Renal Disease (ESRD) Quality Incentive Program (QIP) for Payment Years (PY) 2013 and 2014
Provisions for Assessing theQuality of Anemia Management with Erythropoiesis-Stimulating Agents (ESAs)
Provisions for Assessing theQuality of Anemia Management with Erythropoiesis-Stimulating Agents (ESAs)